Bold opening: Two rising stars from the AHL have been sidelined for a significant stretch due to a breach of the league’s Performance Enhancing Substance Program. But here’s the full picture—and why it matters for teams, players, and fans alike.
IceHogs goaltender Stanislav Berezhnoy and Coachella Valley Firebirds forward David Goyette have both received 20-game suspensions after violations of the AHL/PHPA Performance Enhancing Substance (PESP) policy. The penalties are identical in length, underscoring the league’s firm stance on compliance and player health.
Berezhnoy has already served one game of his suspension and will be eligible to rejoin the Rockford IceHogs for their April 11 matchup. Goyette, meanwhile, will be eligible to return for the Firebirds on April 10.
While the suspensions are substantial, they also highlight the ongoing scrutiny and enforcement of PED-related rules within professional hockey, a topic that often sparks debate regarding fairness, testing rigor, and the balance between talent development and safety.
Question for readers: Do you think the current PED policies strike the right balance between player privacy, health, and fair play, or should there be changes in how suspensions are communicated and enforced? Share your perspective in the comments.
